A citation-based method for searching scientific literature

Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill, Beth Borowsky, Allan J Tobin, H Diana Rosas, Hans Johnson, Ralf Reilmann, Bernhard Landwehrmeyer, Julie C Stout. Lancet Neurol 2009
Times Cited: 624







List of co-cited articles
672 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson,[...]. Lancet Neurol 2013
474
38

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
377
31

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
346
29

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
526
29

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
460
28


Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
509
23

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
17

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
246
17

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
535
17

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
876
16

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
H Diana Rosas, David H Salat, Stephanie Y Lee, Alexandra K Zaleta, Vasanth Pappu, Bruce Fischl, Doug Greve, Nathanael Hevelone, Steven M Hersch. Brain 2008
314
16

Huntington's disease.
Francis O Walker. Lancet 2007
15

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study.
Stefan Klöppel, Sarah Gregory, Elisa Scheller, Lora Minkova, Adeel Razi, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Marina Papoutsi, G Bernhard Landwehrmeyer,[...]. EBioMedicine 2015
78
17

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
128
14

Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
233
13

Longitudinal change in regional brain volumes in prodromal Huntington disease.
Elizabeth H Aylward, Peggy C Nopoulos, Christopher A Ross, Douglas R Langbehn, Ronald K Pierson, James A Mills, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2011
162
12

Behavioral changes in Huntington Disease.
D Craufurd, J C Thompson, J S Snowden. Neuropsychiatry Neuropsychol Behav Neurol 2001
267
12

Huntington disease: clinical care and evaluation.
I Shoulson, S Fahn. Neurology 1979
550
11

Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
138
11

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
515
11

Huntington's disease: a clinical review.
P McColgan, S J Tabrizi. Eur J Neurol 2018
240
11

Striatal and white matter predictors of estimated diagnosis for Huntington disease.
Jane S Paulsen, Peggy C Nopoulos, Elizabeth Aylward, Christopher A Ross, Hans Johnson, Vincent A Magnotta, Andrew Juhl, Ronald K Pierson, James Mills, Douglas Langbehn,[...]. Brain Res Bull 2010
163
10

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Juan F Domínguez D, Gary F Egan, Marcus A Gray, Govinda R Poudel, Andrew Churchyard, Phyllis Chua, Julie C Stout, Nellie Georgiou-Karistianis. PLoS One 2013
59
16


The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
9

Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Andrew Churchyard, Phyllis Chua, Gary F Egan, Nellie Georgiou-Karistianis. Neurobiol Dis 2015
56
16

White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Louisa Salmon, Andrew Churchyard, Phyllis Chua, Nellie Georgiou-Karistianis, Gary F Egan. Neurobiol Dis 2014
62
14

Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
N Georgiou-Karistianis, M A Gray, J F Domínguez D, A R Dymowski, I Bohanna, L A Johnston, A Churchyard, P Chua, J C Stout, G F Egan. Neurobiol Dis 2013
55
16

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
Saul Martinez-Horta, Jesus Perez-Perez, Erik van Duijn, Ramon Fernandez-Bobadilla, Mar Carceller, Javier Pagonabarraga, Berta Pascual-Sedano, Antonia Campolongo, Jesus Ruiz-Idiago, Frederic Sampedro,[...]. Parkinsonism Relat Disord 2016
68
13

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2010
201
9

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
Erik van Duijn, David Craufurd, Anna A M Hubers, Erik J Giltay, Raphael Bonelli, Hugh Rickards, Karen E Anderson, Marleen R van Walsem, Rose C van der Mast, Michael Orth,[...]. J Neurol Neurosurg Psychiatry 2014
122
9

Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.
Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Julie C Stout. Biol Psychiatry 2007
259
9

Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Nellie Georgiou-Karistianis, Govinda R Poudel, Juan F Domínguez D, Rebecca Langmaid, Marcus A Gray, Andrew Churchyard, Phyllis Chua, Beth Borowsky, Gary F Egan, Julie C Stout. Brain Cogn 2013
41
19

Cerebral cortex structure in prodromal Huntington disease.
Peggy C Nopoulos, Elizabeth H Aylward, Christopher A Ross, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Ronald K Pierson, James Mills, Douglas R Langbehn, Jane S Paulsen. Neurobiol Dis 2010
93
8

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
224
8

Huntington's disease: a clinical review.
Raymund A C Roos. Orphanet J Rare Dis 2010
396
8

Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials.
Nellie Georgiou-Karistianis, Rachael Scahill, Sarah J Tabrizi, Ferdinando Squitieri, Elizabeth Aylward. Neurosci Biobehav Rev 2013
57
14

Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.
Peter McColgan, Kiran K Seunarine, Adeel Razi, James H Cole, Sarah Gregory, Alexandra Durr, Raymund A C Roos, Julie C Stout, Bernhard Landwehrmeyer, Rachael I Scahill,[...]. Brain 2015
50
16

Neuropsychiatric aspects of Huntington's disease.
J S Paulsen, R E Ready, J M Hamilton, M S Mega, J L Cummings. J Neurol Neurosurg Psychiatry 2001
262
8

Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.
Georg B Landwehrmeyer, Cheryl J Fitzer-Attas, Joseph D Giuliano, Nilza Gonçalves, Karen E Anderson, Francisco Cardoso, Joaquim J Ferreira, Tiago A Mestre, Julie C Stout, Cristina Sampaio. Mov Disord Clin Pract 2016
77
10

Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.
Christopher A Ross, Ralf Reilmann, Francisco Cardoso, Elizabeth A McCusker, Claudia M Testa, Julie C Stout, Blair R Leavitt, Zhong Pei, Bernhard Landwehrmeyer, Asuncion Martinez,[...]. Mov Disord Clin Pract 2019
20
40

Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".
H Diana Rosas, Stephanie Y Lee, Alexander C Bender, Alexandra K Zaleta, Mark Vangel, Peng Yu, Bruce Fischl, Vasanth Pappu, Christina Onorato, Jang-Ho Cha,[...]. Neuroimage 2010
177
7

Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
Juan F Domínguez D, Julie C Stout, Govinda Poudel, Andrew Churchyard, Phyllis Chua, Gary F Egan, Nellie Georgiou-Karistianis. Br J Psychiatry 2016
23
30

Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.
Jennifer C Thompson, Jenny Harris, Andrea C Sollom, Cheryl L Stopford, Elizabeth Howard, Julie S Snowden, David Craufurd. J Neuropsychiatry Clin Neurosci 2012
103
7

Social cognition in Huntington's disease: A meta-analysis.
Emre Bora, Dennis Velakoulis, Mark Walterfang. Behav Brain Res 2016
48
14

Onset and rate of striatal atrophy in preclinical Huntington disease.
E H Aylward, B F Sparks, K M Field, V Yallapragada, B D Shpritz, A Rosenblatt, J Brandt, L M Gourley, K Liang, H Zhou,[...]. Neurology 2004
285
7

Regional and progressive thinning of the cortical ribbon in Huntington's disease.
H D Rosas, A K Liu, S Hersch, M Glessner, R J Ferrante, D H Salat, A van der Kouwe, B G Jenkins, A M Dale, B Fischl. Neurology 2002
770
7

Therapies targeting DNA and RNA in Huntington's disease.
Edward J Wild, Sarah J Tabrizi. Lancet Neurol 2017
126
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.